The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions

Pixelligent Technologies

Advised Pixelligent Technologies, a developer and manufacturer of nanocrystal material used in consumer electronic devices, on a significant strategic investment from Henkel Corporation, a publicly traded (FWB: HEN) German multinational chemical and consumer goods company

Summit Electric Supply Co., Inc.

Advised Summit Electric Supply Co., Inc, a founder and family-owned electrical distributor with operations across Arizona, Louisiana, New Mexico and Texas, on its sale to Sonepar USA Holdings, Inc., an independent, family-owned company with global market leadership in the B2B distribution of electrical products, solutions and related services

Danfoss Fire Safety A/S

Advising Danfoss A/S, one of the largest industrial groups in Denmark, on the sale of Danfoss Fire Safety A/S, a leading provider of certified fixed firefighting systems, to Siemens AG through its Smart Infrastructure segment

Radio Frequency Components Business of Renesas Electronics Corporation

Exclusive advisor to Renesas, a global provider of microcontrollers, combining expertise in embedded processing, analog, power and connectivity to deliver complete semiconductor solutions

Robertet SA

Advising Fonds Stratégique de Participations and Peugeot Invest SA, on the acquisition of a 14% stake for €250 million in Robertet SA, world leader in natural products, from DSM-Firmenich AG

Centogene GmbH

Advising Charme Capital Partners, a European mid-market private equity fund, on the acquisition of Centogene GmbH, a leading provider of pharmaceutical solutions and diagnostic tests for rare diseases

Ex-US rights to branded narcolepsy treatments, Provigil® (modafinil) and Nuvigil® (armodafinil)

Advised Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company, on the acquisition of the ex-US rights to Provigil® (modafinil) and Nuvigil® (armodafinil) from Teva Pharmaceuticals Industries Ltd. (“Teva”)

Renewi plc

Advising Renewi plc, a leading European waste-to-product company, on its £707 million recommended cash offer for its entire issued share capital from a consortium controlled by Macquarie Asset Management and British Columbia Infrastructure Management Corporation (BCI)

German Doner Kebab ("GDK")

Advised Hero Brands on the strategic investment in GDK by True. GDK is a leading Middle Eastern quick-service restaurant brand, with over 145 franchised locations in the UK and 170 globally, including the US, Canada, Sweden and the Middle East

EYSA

Advising Tikehau Capital, global mid-market fund headquartered in France, in the acquisition of EYSA, a leading provider of smart mobility solutions, focusing on both urban and interurban mobility services for municipalities, transport authorities and infrastructure owners

Environmental technology business of Dürr AG

Advising Dürr AG, one of the world's leading mechanical and plant engineering firms, on the sale of its environmental technology business to Stellex Capital Management LLC for an enterprise value of ~$450 million